IORT-Boost-Study, Prospective Observational Study for Intraoperative Radiotherapy of the Breast as a Boost
NCT ID: NCT02114086
Last Updated: 2022-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
163 participants
OBSERVATIONAL
2013-01-31
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Boost Versus no Boost Irradiation of Early Breast Cancer
NCT02295033
Intraoperative Radiotherapy for Korean Patients With Breast Cancer
NCT02213991
IORT (Intra-operative Radiation Therapy) in Early Stage Breast Cancer
NCT01988870
Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer
NCT02040493
Intra-Operative Radiation Registry
NCT04994067
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
breast cancer
observation of intraoperative radiotherapy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
* ability to cooperate
* full legal capability
Exclusion Criteria
* lack of compliance
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Münsterlingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christiane Reuter, Dr. med.
Role: STUDY_DIRECTOR
Kantonsspital Münsterlingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KMünsterlingen
Münsterlingen, Thurgau, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Warlam-Rodenhuis CC, Pierart M, Collette L. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007 Aug 1;25(22):3259-65. doi: 10.1200/JCO.2007.11.4991. Epub 2007 Jun 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMünsterlingen
Identifier Type: OTHER
Identifier Source: secondary_id
ROKSM 01/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.